Liaoning OxiranchemInc Bilan de santé

Santé financière contrôle des critères 2/6

Liaoning OxiranchemInc possède un total de capitaux propres de CN¥3.0B et une dette totale de CN¥1.6B, ce qui porte son ratio d'endettement à 53.9%. Son actif total et son passif total sont CN¥5.4B et de CN¥2.4B.

Informations clés

53.9%

Ratio d'endettement

CN¥1.63b

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	CN¥286.25m
Fonds propres	CN¥3.03b
Total du passif	CN¥2.37b
Total des actifs	CN¥5.40b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Liaoning Oxiranchem,Inc.'s (SZSE:300082) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Nov 22

Liaoning Oxiranchem,Inc. (SZSE:300082) Soars 32% But It's A Story Of Risk Vs Reward

Sep 02

Liaoning Oxiranchem,Inc. (SZSE:300082) Stock Rockets 27% But Many Are Still Ignoring The Company

Mar 08

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 300082 ( CN¥2.1B ) dépassent ses passifs à court terme ( CN¥2.1B ).

Passif à long terme: Les actifs à court terme de 300082 ( CN¥2.1B ) dépassent ses passifs à long terme ( CN¥307.5M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 300082 ( 44.4% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de 300082 est passé de 26.3% à 53.9% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de 300082 est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de 300082 sur sa dette sont bien couverts par l'EBIT.

Liaoning OxiranchemInc Bilan de santé

Santé financière contrôle des critères 2/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

New major risk - Share price stability

Liaoning Oxiranchem,Inc.'s (SZSE:300082) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Third quarter 2024 earnings released: CN¥0.05 loss per share (vs CN¥0.061 loss in 3Q 2023)

Liaoning Oxiranchem,Inc. to Report Q3, 2024 Results on Oct 28, 2024

Liaoning Oxiranchem,Inc. (SZSE:300082) Soars 32% But It's A Story Of Risk Vs Reward

New minor risk - Share price stability

Second quarter 2024 earnings released: CN¥0.032 loss per share (vs CN¥0.13 loss in 2Q 2023)

Liaoning Oxiranchem,Inc. to Report First Half, 2024 Results on Aug 06, 2024

First quarter 2024 earnings released: CN¥0.12 loss per share (vs CN¥0.09 loss in 1Q 2023)

Liaoning Oxiranchem,Inc., Annual General Meeting, May 20, 2024

New minor risk - Share price stability

Liaoning Oxiranchem,Inc. to Report Q1, 2024 Results on Apr 23, 2024

Liaoning Oxiranchem,Inc. (SZSE:300082) Stock Rockets 27% But Many Are Still Ignoring The Company

Liaoning Oxiranchem,Inc. to Report Fiscal Year 2023 Results on Apr 23, 2024

Third quarter 2023 earnings released: CN¥0.061 loss per share (vs CN¥0.067 loss in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.074 loss in 2Q 2022)

Full year 2022 earnings released: EPS: CN¥0.01 (vs CN¥0.52 in FY 2021)

Investor sentiment improves as stock rises 16%

Price target decreased to CN¥11.00

Insufficient new directors

Insufficient new directors

Third quarter 2022 earnings released: CN¥0.031 loss per share (vs CN¥0.16 profit in 3Q 2021)

Insufficient new directors

Liaoning Oxiranchem,Inc. Approves Election Directors

Investor sentiment improved over the past week

Second quarter 2022 earnings released: CN¥0.074 loss per share (vs CN¥0.043 profit in 2Q 2021)

Liaoning Oxiranchem,Inc. Approves Final Cash Dividend for the Year 2021

Liaoning Oxiranchem,Inc. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.24 in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.043 (vs CN¥0.18 in 2Q 2020)

Price target decreased to CN¥12.50

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Liaoning Oxiranchem,Inc. Approves Final Cash Dividend

Price target increased to CN¥14.13

Full year 2020 earnings released: EPS CN¥0.59 (vs CN¥0.51 in FY 2019)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Liaoning Oxiranchem,Inc. to Report Fiscal Year 2020 Results on Apr 20, 2021

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥12.50

New 90-day low: CN¥8.37

Liaoning Oxiranchem,Inc. (SZSE:300082) signed the agreement to acquire 67% stake in Liaoning Oxiranphex Inc. from Oxiranchem Holding Group Co., Ltd. and Dalian Jixing Venture Capital Partnership Enterprise (Limited Partnership) for approximately CNY 170 million.

New 90-day high: CN¥11.15

New 90-day high: CN¥11.00

Third quarter earnings released

Market bids up stock over the past week

New 90-day high: CN¥10.01

Liaoning Oxiranchem,Inc. (SZSE:300082) signed an agreement to acquire 24.24% stake in Suzhou Huayi new energy technology co., LTD. from Gu Hongxia for CNY 40 million.

New 90-day high - CN¥9.89

First half earnings released

New 90-day high - CN¥9.32

Liaoning Oxiranchem,Inc. to Report First Half, 2020 Results on Aug 20, 2020

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines